Quanome agrees to acquire 5% stake in QAI Labs in USD 5 million all-stock deal

• Quanome Technologies agreed November 4, 2026, to acquire approximately 5% of QAI Labs in an all-stock investment valued at US$5 million.
• QAI Labs will issue 31,579 new shares in exchange for 6,541,236 new shares of the investor's common stock.
• The common stock issuance represents approximately 19% of outstanding shares before issuance, or 15.97% following issuance.
• The transaction implies an equity valuation of approximately US$100 million for QAI Labs, which will remain independent.
• The investment targets AI-driven antibody discovery; closing remains subject to customary conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quanome Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-117226), on November 09, 2026, and is solely responsible for the information contained therein.